Search / Trial NCT06233409

A Novel Sandwich Technique of Minimally Invasive Keratoplasty for Corneal Perforation

Launched by TIANJIN EYE HOSPITAL · Jan 30, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Corneal Perforation, Corneal Stromal Lenticule,Sandwich Technique

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with corneal perforation who are willing to undergo treatment with this new technique;
  • 2. The size of cornea perforation was ≦ 3mm
  • Exclusion Criteria:
  • 1. The size of cornea perforation was \>3mm
  • 2. Patients with corneal perforation who were unwilling to be treated with this new technique.
  • 3. Patients who could not be followed up regularly.

About Tianjin Eye Hospital

Tianjin Eye Hospital is a leading medical institution specializing in ophthalmology, dedicated to advancing eye health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital is committed to conducting rigorous studies that explore new treatments and therapies for a variety of eye-related conditions. With state-of-the-art facilities and a team of experienced professionals, Tianjin Eye Hospital fosters collaboration with researchers and healthcare providers to enhance patient care and contribute to the global understanding of ocular health. Its focus on patient-centered research ensures that clinical trials are designed to prioritize safety, efficacy, and the well-being of participants.

Locations

Tianjin, Tianjin, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0